You have 9 free searches left this month | for more free features.

Lymphoma, B-Cell, Marginal Zone

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Marginal Zone Lymphoma, Follicular Lymphoma Trial in Aurora (Ublituximab, Umbralisib)

Suspended
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • Aurora, Colorado
    University of Colorado Hospital
Feb 22, 2022

Marginal Zone Lymphoma Trial in Miami (Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg)

Recruiting
  • Marginal Zone Lymphoma
  • Loncastuximab tesirine 150 µg/Kg
  • Loncastuximab tesirine 75µg/Kg
  • Miami, Florida
    University of Miami
Jul 12, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 20, 2022

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • Westbury, New York
    Clinical Research Alliance, Inc.
Mar 29, 2022

Follicular Lymphoma ( FL), Marginal Zone Lymphoma (MZL) Trial (parsaclisib, rituximab, obinutuzumab)

Withdrawn
  • Follicular Lymphoma ( FL)
  • Marginal Zone Lymphoma (MZL)
  • (no location specified)
Jul 14, 2022

Integrated Molecular and Clinical Profiling to Optimize Outcome

Completed
  • Splenic Marginal Zone Lymphoma
    • Bellinzona, Switzerland
      IOSI
    Jun 4, 2021

    B-cell Chronic Lymphoid Malignancies Markers

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
      • Strasbourg, France
        Hematology Laboratory - Strasbourg University Hospitals
      Jul 2, 2021

      Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

      Recruiting
      • Follicular Lymphoma
      • +2 more
      • Laboratory Biomarker Analysis
      • Pembrolizumab
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Apr 11, 2022

      Follicular Lymphoma (Gastric or Duodenal), Marginal Zone Lymphoma (Gastric or Duodenal) Trial in Münster (Radiation Therapy)

      Recruiting
      • Follicular Lymphoma (Gastric or Duodenal)
      • Marginal Zone Lymphoma (Gastric or Duodenal)
      • Radiation Therapy
      • Münster, North Rhine-Westphalia, Germany
        Department of Radiation Oncology
      Dec 1, 2021

      Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

      Completed
      • Marginal Zone Lymphoma
      • +2 more
      • Harbin, Heilongjiang, China
      • +3 more
      Oct 26, 2021

      Marginal Zone Lymphoma Trial in Zhengzhou (Bortezomib, Rituximab, Epirubicin)

      Recruiting
      • Marginal Zone Lymphoma
      • Zhengzhou, Henan, China
        Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
      Aug 15, 2021

      Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal

      Completed
      • Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
      • +2 more
      • Radiation Therapy
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 25, 2022

      Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Miami (Acalabrutinib,

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Miami, Florida
        University of Miami
      Oct 25, 2021

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,

      Suspended
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +23 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 23, 2022

      Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

      Not yet recruiting
      • Mature B-Cell Neoplasm
      • +25 more
      • (no location specified)
      Sep 14, 2022

      Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62 Injection,

      Recruiting
      • Follicular Lymphoma and Marginal Zone Lymphoma
      • Recombinant Humanized Monoclonal Antibody MIL62 Injection
      • Lenalidomide
      • Beijing, China
        Chinese Academy of Medical Sciences and Peking Union Medical Col
      Jun 15, 2021

      Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • Registry of patients (exposure is Cutaneous Lymphoma)
      • Barcelona, Spain
      • +13 more
      Mar 15, 2022

      Marginal Zone B-cell Lymphoma Trial in Korea, Republic of (bendamustine plus rituximab)

      Completed
      • Marginal Zone B-cell Lymphoma
      • bendamustine plus rituximab
      • Jeonju, Jeollabuk-do, Korea, Republic of
      • +10 more
      Sep 23, 2021

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

      Active, not recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +9 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 3, 2022

      Follicular Lymphoma and Marginal Zone Lymphoma Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide,

      Recruiting
      • Follicular Lymphoma and Marginal Zone Lymphoma
      • Recombinant Humanized Monoclonal Antibody MIL62, lenalinomide
      • lenalinomide
      • Beijing, China
        Chinese Academy of Medical Sciences and Peking Union Medical Col
      Feb 13, 2022

      Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

      Recruiting
      • Mantle Cell Lymphoma
      • +5 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Nov 19, 2021

      Marginal Zone Lymphoma Trial in Germany (Obinutuzumab)

      Recruiting
      • Marginal Zone Lymphoma
      • Bochum, Germany
      • +15 more
      Mar 14, 2022